Effects of previous episodes of influenza and vaccination in preventing laboratory-confirmed influenza in Navarre, Spain, 2013/14 season

Eurosurveillance

Volumn 21, Issue 22, 2016, Pages 1-10

  Castilla, Jesús ^a,b,k   Navascues A ^c   Fernandez Alonso M ^d   Reina, G ^d   Albeniz E ^a   Pozo, F ^e   Alvarez N ^a,f,j   Martinez Baz I ^a,b   Guevara, M ^a,b   Garcia Cenoz M ^a,b,k   Irisarri, F ^a,b,k   Casado, I ^a,b   Ezpeleta, C ^c   Abad, I ^g   Aldaz, P ^g   Alvarez E ^g   Alvarez, N ^g   Arana, J J ^g   Arceiz, I ^g   Arina, E ^g   Arribas, I ^g   Artajo, M D ^g   Azagra, B ^g   Bartolome, F C ^g   Bolea, C ^g   Brugos, A ^g   Cano, B ^g   Castresana, M V ^g   Cenoz, J C ^g   Cia, F ^g   Compains, B ^g   Cortes F ^g   Churio B ^g   Cuevas, P C ^g   Da Costa, E M ^g   Espino, J Díez ^g   Doiz, M ^g   Escribano, F J ^g   Esparza, M J ^g   Etayo, V ^g   Alfaro, C Fernández ^g   Flamarique, B ^g   Gamboa, J ^g   Garces M L ^g   Blanco, L García ^g   German, A B ^g   Giner, A ^g   Goni N ^g   Guillorme, M J ^g   Guiu, J O ^g   Gurbindo, J C ^g   Guruchaga, M J ^g   Heras, J A ^g   Hijos, M C ^g   Huidobro, J ^g   Indurain, S ^g   Inigo B ^g   Irigoyen, M C ^g   Jurio, J J ^g   Leon M P ^g   Longas J J ^g   Lopez M J ^g   Maquirriain, M T ^g   Miner, J J ^g   Moreno, M ^g   Moros, M A ^g   Navarro, U ^g   Orozco, F J ^g   Orte, M ^g   Palacio, P ^g   Palau, J ^g   Lecumberri, C Pérez ^g   Pascual, P Pérez ^g   Sanz, B Pérez ^g   Prado, A ^g   Prado, M ^g   Puig, A ^g   Ridruejo, E ^g   Ramos, M ^g   Ripodas B E ^g   Rodriguez M ^g   Roncal, M A ^g   Puertas, I Ruiz ^g   Sanchez C ^g   Sarrasqueta, P ^g   Senosiain, M A ^g   Sola, J ^g   Sota, M ^g   Ursua, M E ^g   Urtasun, I A ^g   Vigata, M J ^g   Virto, M T ^g   Artajo, P ^c   Beristain, X ^c   Bernaola, E ^c   Chamorro, J ^c   Esquiroz, M ^c   Fanlo, P ^c   Gil, F ^c   Gabari, M ^c   Hueto, J ^c   Martin C ^c   Pena L ^c   Perez C ^c   Polo, I ^c   Ruiz, M ^c   Viguria, N ^c   Nunez J ^d   Irure, J J García ^h   Ortega, M ^h   Torres, M ^h   Lameiro, F ⁱ   Barrado, L ⁱ   Zabala, A ^k   Arriazu, M ^k   Barricarte, A ^k   more..

^a IdiSNA Navarra Institute for Health Research   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c Instituto de Investigación Sanitaria de Navarra   (Spain)

^d UNIVERSITY CLINIC OF NAVARRA   (Spain)

^e WORLD HEALTH ORGANIZATION   (Switzerland)

^f Navarrabiomed Fundación Miguel Servet Red de Investigación en Servicios de Salud en Enfermedades Crónicas REDISSEC   (Spain)

^g Clínica Universidad de Navarra ^*

^h Anatomía Patológica del Hospital Reina Sofía de Tudela   (Bulgaria)

ⁱ HOSPITAL GARCÍA ORCOYEN   (Spain)

^j Servicio Navarro de Salud   (Spain)

^k INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

TRIPLE VACCINE; INFLUENZA VACCINE; VACCINE;

ARTICLE; CROSS PROTECTION; HUMAN; IMMUNE RESPONSE; INFLUENZA; INFLUENZA A (H1N1); INFLUENZA A (H3N2); NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SPAIN; STUDY DESIGN; VACCINATION; ADOLESCENT; ADULT; AGED; CASE CONTROL STUDY; CHILD; FEMALE; HEALTH SURVEY; IMMUNOLOGY; INFLUENZA A VIRUS (H1N1); INFLUENZA A VIRUS (H3N2); INFLUENZA B VIRUS; INFLUENZA, HUMAN; ISOLATION AND PURIFICATION; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIMARY HEALTH CARE; PROCEDURES; SEASON; SENSITIVITY AND SPECIFICITY; SENTINEL SURVEILLANCE; STATISTICS AND NUMERICAL DATA; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA B VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); POLYMERASE CHAIN REACTION; POPULATION SURVEILLANCE; PRIMARY HEALTH CARE; SEASONS; SENSITIVITY AND SPECIFICITY; SENTINEL SURVEILLANCE; SPAIN; VACCINATION; VACCINE POTENCY; YOUNG ADULT;

EID: 85014122818     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/1560-7917.ES.2016.21.22.30243     Document Type: Article

References (26)

1. World Health Organization (WHO). Fact sheet No 211. Influenza (seasonal). Geneva: WHO; April 2009. Available from: http:// www.who.int/mediacentre/factsheets/fs211/en/index.html
2. European Centre for Disease Prevention and Control (ECDC). Influenza virus characterization. Surveillance report. Stockholm: ECDC; December 2013. Available from: http:// www.ecdc.europa.eu/en/healthtopics/seasonal_influenza/ epidemiological_data/Pages/Influenza_virus_characterisation. aspx
3. Sauerbrei A, Langenhan T, Brandstadt A, Schmidt-Ott R, Krumbholz A, Girschick H, et al. Prevalence of antibodies against influenza A and B viruses in children in Germany, 2008 to 2010. Euro Surveill. 2014;19(5):20687. DOI: 10.2807/1560-7917.ES2014.19.5.20687 PMID: 24524235
4. Ohmit SE, Petrie JG, Cross RT, Johnson E, Monto AS. Influenza hemagglutination-inhibition antibody titer as a correlate of vaccine-induced protection.J Infect Dis. 2011;204(12):1879-85. DOI: 10.1093/infdis/jir661 PMID: 21998477
5. Epstein SL, Lo CY, Misplon JA, Bennink JR. Mechanism of protective immunity against influenza virus infection in mice without antibodies.J Immunol. 1998;160(1):322-7.PMID: 9551987
6. Recommended composition of influenza virus vaccines for use in the 2013-2014 northern hemisphere influenza season. Wkly Epidemiol Rec. 2013;88(10):101-14.PMID: 23544236
7. Adlhoch C, Broberg E, Beaute J, Snacken R, Bancroft E, Zucs P, et al. Influenza season 2013/14 has started in Europe with influenza A(H1)pdm09 virus being the most prevalent subtype. Euro Surveill. 2014;19(4):20686. DOI: 10.2807/1560-7917. ES2014.19.4.20686 PMID: 24507465
8. Sistema de Vigilancia de la Gripe en Espana. Informe semanal 4/2014. [Report of the influenza surveillance system in Spain 4/2014]. Madrid: Instituto de Salud Carlos III; 30 January 2014. N° 378. Spanish. Available from: http://vgripe.isciii.es/gripe/ documentos/20132014/boletines/grn042014.pdf
9. European Centre for Disease Prevention and Control. Weekly influenza surveillance overview. 31 January 2014. Available from: http://www.ecdc.europa.eu/en/publications/ Publications/influenza-surveillance-overview-31-jan-2014.pdf
10. Hoskins TW, Davies JR, Smith AJ, Miller CL, Allchin A. Assessment of inactivated influenza-A vaccine after three outbreaks of influenza A at Christ's Hospital.Lancet. 1979;1(8106):33-5. DOI: 10.1016/S0140-6736(79)90468-9 PMID: 83475
11. Davies JR, Grilli EA. Natural or vaccine-induced antibody as a predictor of immunity in the face of natural challenge with influenza viruses.Epidemiol Infect. 1989;102(2):325-33. DOI: 10.1017/S0950268800030004 PMID: 2703026
12. Instituto de Salud Publica y Laboral de Navarra. Protocolo de vacunacion antigripal 2013-2014 [Influenza vaccination protocol 2013-2014]. Boletin Informativo. 2013;74. Spanish. Available from: http://www.navarra.es/NR/rdonlyres/ AECCD760-AB2A-4841-818A-FA53478FD6DC/275548/ BOL74INTCampana20132014_ModificadoFeb2014.pdf
13. Aguilar I, Reyes M, Martinez-Baz I, Guevara M, Albeniz E, Belza M, et al. Use of the vaccination register to evaluate influenza vaccine coverage in seniors in the 2010/11 influenza season, Navarre, Spain. Euro Surveill. 2012;17(17):20154.PMID: 22551499
14. McLean HQ, Thompson MG, Sundaram ME, Meece JK, McClure DL, Friedrich TC, et al. Impact of repeated vaccination on vaccine effectiveness against influenza A(H3N2) and B during 8 seasons. Clin Infect Dis. 2014;59(10):1375-85. DOI: 10.1093/cid/ ciu680 PMID: 25270645
15. Wei CJ, Yassine HM, McTamney PM, Gall JG, Whittle JR, Boyington JC, et al. Elicitation of broadly neutralizing influenza antibodies in animals with previous influenza exposure. Sci Transl Med. 2012;4(147):147ra114.13.
16. He XS, Holmes TH, Sanyal M, Albrecht RA, Garcia-Sastre A, Dekker CL, et al. Distinct patterns of B-cell activation and priming by natural influenza virus infection versus inactivated influenza vaccination. J Infect Dis. 2015;211(7):1051-9. DOI: 10.1093/infdis/jiu580 PMID: 25336731
17. Castilla J, Martinez-Baz I, Navascues A, Fernandez-Alonso M, Reina G, Guevara M, et al. Vaccine effectiveness in preventing laboratory-confirmed influenza in Navarre, Spain: 2013/14 mid-season analysis. Euro Surveill. 2014;19(6):20700. DOI: 10.2807/1560-7917.ES2014.19.6.20700 PMID: 24556347
18. Jimnez-Jorge S, Pozo F, de Mateo S, Delgado-Sanz C, Casas I, Garcia-Cenoz M, et al. Influenza vaccine effectiveness in Spain 2013/14: subtype-specific early estimates using the cycEVA study. Euro Surveill. 2014;19(9):20727. DOI: 10.2807/1560-7917.ES2014.19.9.20727 PMID: 24626206
19. Valenciano M, Kissling E, Reuss A, Jimenez-Jorge S, Horvath JK, Donnell JM, et al. The European I-MOVE Multicentre 2013-2014 Case-Control Study. Homogeneous moderate influenza vaccine effectiveness against A(H1N1)pdm09 and heterogenous results by country against A(H3N2). Vaccine. 2015;33(24):2813-22. DOI: 10.1016/j.vaccine.2015.04.012 PMID: 25936723
20. Lytras T, Kossyvakis A, Melidou A, Exindari M, Gioula G, Pogka V, et al. Influenza vaccine effectiveness against laboratory confirmed influenza in Greece during the 2013-2014 season: a test-negative study. Vaccine. 2015;33(2):367-73. DOI: 10.1016/j. vaccine.2014.11.005 PMID: 25448097
21. Turner N, Pierse N, Bissielo A, Huang Q, Radke S, Baker M, et al. Effectiveness of seasonal trivalent inactivated influenza vaccine in preventing influenza hospitalisations and primary care visits in Auckland, New Zealand, in 2013. Euro Surveill. 2014;19(34):20884. DOI: 10.2807/1560-7917. ES2014.19.34.20884 PMID: 25188614
22. McNeil S, Shinde V, Andrew M, Hatchette T, Leblanc J, Ambrose A, et al. Interim estimates of 2013/14 influenza clinical severity and vaccine effectiveness in the prevention of laboratory-confirmed influenza-related hospitalisation, Canada, February 2014. Euro Surveill. 2014;19(9):20729. DOI: 10.2807/1560-7917.ES2014.19.9.20729 PMID: 24626207
23. Skowronski D, Chambers C, Sabaiduc S, De Serres G, Dickinson J, Winter A, et al. Interim estimates of 2013/14 vaccine effectiveness against influenza A(H1N1)pdm09 from Canada s sentinel surveillance network, January 2014. Euro Surveill. 2014;19(5):20690. DOI: 10.2807/1560-7917. ES2014.19.5.20690 PMID: 24524234
24. Wilde JA, McMillan JA, Serwint J, Butta J, O'Riordan MA, Steinhoff MC. Effectiveness of influenza vaccine in health care professionals: a randomized trial.JAMA. 1999;281(10):908-13. DOI: 10.1001/jama.281.10.908 PMID: 10078487
25. Burgui R, Martinez-Baz I, Guevara M, Carlos S, Castilla J. Use of medical care during pandemic (H1N1) 2009, Navarre, Spain. Emerg Infect Dis. 2011;17(8):1463-6.PMID: 21801624
26. Valenciano M, Kissling E, Ciancio BC, Moren A. Study designs for timely estimation of influenza vaccine effectiveness using European sentinel practitioner networks.Vaccine. 2010;28(46):7381-8. DOI: 10.1016/j.vaccine.2010.09.010 PMID: 20851086